Below is a comprehensive archive of press releases from MSF-USA. Use the options in the boxes below to filter results based on your preferences.

December 10, 2010

MSF joins other advocates for people living with HIV/AIDS to demand the EU stop pursuing measures that undermine India’s role as producer of affordable life-saving generic medicines

December 07, 2010

Several low-income countries highly affected by HIV risk being entirely or partly disqualified from the current funding round by the Global Fund to Fight AIDS, Tuberculosis and Malaria.

November 29, 2010

HIV/AIDS treatment in developing countries is being dealt a double blow that will mean treatment recommendations cannot be implemented and the promise of new scientific research will remain unfulfilled.

November 18, 2010

The dual epidemic of tuberculosis and HIV is devastating Swaziland, cutting life expectancy there from 60 to just 31 years of age, MSF said today in a new report.

September 30, 2010

Geneva/New York – September 30, 2010 – The U.S. National Institutes of Health (NIH) announced today it will license a patent for an HIV medicine to the Medicines Patent Pool, a mechanism designed to boost access to more affordable AIDS drugs in the developing world. The move acts as a wake-up call to pharmaceutical companies to put patents on key AIDS medicines into the pool, said the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF).

September 16, 2010

The fight against childhood malnutrition and HIV could be transformed by innovative funding mechanisms currently tabled at UN Millennium Development Goals Summit.

September 06, 2010

Brussels, September 6, 2010—As finance ministers from the European Union gather in Brussels for a formal meeting to discuss the establishment of an EU-wide financial transaction tax, MSF calls on them to dedicate a proportion of the receipts from any fundraising mechanism to global health.

July 19, 2010

International donors are disregarding scientific evidence and seeking short-term cost savings at the expense of ten million people in need of treatment for HIV/AIDS.

May 26, 2010

Johanesburg/New York, May 27, 2010 - Backtracking by international donors of HIV/AIDS treatment risks undermining years of positive achievements and will cause many more unnecessary deaths, warned the medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) in a new report released today.

May 05, 2010

Valganciclovir is primarily used as treatment and prevention of an infection caused by cytomegalovirus (CMV) in organ transplant patients, a highly lucrative market that Roche has sought to protect by patenting the medicine. But CMV also affects people living with HIV, and if left untreated, can cause blindness and death.